Financhill
Back

Xtacy Therapeutics Vs. Quinsam Capital Industry Stock Comparison

Sell
32

XTCY.CX
Xtacy Therapeutics

Last Price:
0.03
Seasonality Move:
-22.76%
Sell
40

QCA.CX
Quinsam Capital

Last Price:
0.05
Seasonality Move:
8.91%
Sell
32
Xtacy Therapeutics (XTCY.CX) is a Sell

Is Xtacy Therapeutics a Buy, Sell or Hold?

  • The current Xtacy Therapeutics [XTCY.CX] share price is $0.03. The Score for XTCY.CX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • XTCY.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Quinsam Capital (QCA.CX) is a Sell

Is Quinsam Capital a Buy, Sell or Hold?

  • The current Quinsam Capital [QCA.CX] share price is $0.05. The Score for QCA.CX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • QCA.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTCY.CX Stock Price Chart

What is Xtacy Therapeutics's stock price today?

  • The Xtacy Therapeutics share price today is $0.03
    The current trend is relatively stagnant and XTCY.CX is experiencing slight buying pressure.

QCA.CX Stock Price Chart

What is Quinsam Capital's stock price today?

  • The Quinsam Capital share price today is $0.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QCA.CX is experiencing slight buying pressure.

XTCY.CX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 44.83 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.02 - 0.04) Sell
Bollinger Bands (100): (0.03 - 0.05) Sell

QCA.CX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 45.7 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.05 - 0.05) Sell
Bollinger Bands (100): (0.05 - 0.05) Sell

XTCY.CX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.02 Buy
20-day SMA: 0.03 Sell
50-day SMA: 0.03 Sell
200-day SMA: 0.04 Sell
8-day EMA: 0.02 Buy
20-day EMA: 0.03 Sell
50-day EMA: 0.03 Sell
200-day EMA: 0.04 Sell

QCA.CX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.05 Sell
20-day SMA: 0.05 Sell
50-day SMA: 0.05 Sell
200-day SMA: 0.05 Sell
8-day EMA: 0.05 Sell
20-day EMA: 0.05 Sell
50-day EMA: 0.05 Sell
200-day EMA: 0.05 Sell

Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Quinsam Capital Earnings Growth & QCA.CX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Xtacy Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Quinsam Capital Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):